Antonio
González Martín
Consultor Médico
Università di Udine
Udine, ItaliaPublicaciones en colaboración con investigadores/as de Università di Udine (1)
2016
-
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Annals of Oncology, Vol. 27, Núm. 11, pp. 2046-2052